Your browser doesn't support javascript.
loading
Enhancing epidemiological surveillance of the emergence of the SARS-CoV-2 Omicron variant using spike gene target failure data, England, 15 November to 31 December 2021.
Blomquist, Paula B; Bridgen, Jessica; Bray, Neil; O'Connell, Anne Marie; West, Daniel; Groves, Natalie; Gallagher, Eileen; Utsi, Lara; Jarvis, Christopher I; Hardstaff, Jo L; Byers, Chloe; Metelmann, Soeren; Simons, David; Zaidi, Asad; Twohig, Katherine A; Savagar, Bethan; Løchen, Alessandra; Ryan, Cian; Wrenn, Katie; Saavedra-Campos, María; Abedin, Zahidul; Florence, Isaac; Cleary, Paul; Elson, Richard; Vivancos, Roberto; Lake, Iain R.
Afiliação
  • Blomquist PB; COVID-19 Outbreak Surveillance Team, UK Health Security Agency, London, United Kingdom.
  • Bridgen J; COVID-19 Outbreak Surveillance Team, UK Health Security Agency, London, United Kingdom.
  • Bray N; COVID-19 Outbreak Surveillance Team, UK Health Security Agency, London, United Kingdom.
  • O'Connell AM; COVID-19 Outbreak Surveillance Team, UK Health Security Agency, London, United Kingdom.
  • West D; UK Health Security Agency, London, United Kingdom.
  • Groves N; UK Health Security Agency, London, United Kingdom.
  • Gallagher E; UK Health Security Agency, London, United Kingdom.
  • Utsi L; COVID-19 Outbreak Surveillance Team, UK Health Security Agency, London, United Kingdom.
  • Jarvis CI; COVID-19 Outbreak Surveillance Team, UK Health Security Agency, London, United Kingdom.
  • Hardstaff JL; London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Byers C; COVID-19 Outbreak Surveillance Team, UK Health Security Agency, London, United Kingdom.
  • Metelmann S; COVID-19 Outbreak Surveillance Team, UK Health Security Agency, London, United Kingdom.
  • Simons D; COVID-19 Outbreak Surveillance Team, UK Health Security Agency, London, United Kingdom.
  • Zaidi A; COVID-19 Outbreak Surveillance Team, UK Health Security Agency, London, United Kingdom.
  • Twohig KA; UK Health Security Agency, London, United Kingdom.
  • Savagar B; UK Health Security Agency, London, United Kingdom.
  • Løchen A; COVID-19 Outbreak Surveillance Team, UK Health Security Agency, London, United Kingdom.
  • Ryan C; COVID-19 Outbreak Surveillance Team, UK Health Security Agency, London, United Kingdom.
  • Wrenn K; COVID-19 Outbreak Surveillance Team, UK Health Security Agency, London, United Kingdom.
  • Saavedra-Campos M; COVID-19 Outbreak Surveillance Team, UK Health Security Agency, London, United Kingdom.
  • Abedin Z; COVID-19 Outbreak Surveillance Team, UK Health Security Agency, London, United Kingdom.
  • Florence I; COVID-19 Outbreak Surveillance Team, UK Health Security Agency, London, United Kingdom.
  • Cleary P; UK Health Security Agency, London, United Kingdom.
  • Elson R; COVID-19 Outbreak Surveillance Team, UK Health Security Agency, London, United Kingdom.
  • Vivancos R; COVID-19 Outbreak Surveillance Team, UK Health Security Agency, London, United Kingdom.
  • Lake IR; School of Environmental Sciences, UEA, Norwich, United Kingdom.
Euro Surveill ; 27(11)2022 03.
Article em En | MEDLINE | ID: mdl-35301981
When SARS-CoV-2 Omicron emerged in 2021, S gene target failure enabled differentiation between Omicron and the dominant Delta variant. In England, where S gene target surveillance (SGTS) was already established, this led to rapid identification (within ca 3 days of sample collection) of possible Omicron cases, alongside real-time surveillance and modelling of Omicron growth. SGTS was key to public health action (including case identification and incident management), and we share applied insights on how and when to use SGTS.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Screening_studies Limite: Humans Idioma: En Revista: Euro Surveill Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Screening_studies Limite: Humans Idioma: En Revista: Euro Surveill Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido